Skip to main content

Select Drug Profiles

Transition from Branded to Generic Cancer Drugs Significantly Increases Treatment Cost-Effectiveness

Out-of-Pocket Costs Linked to Reduced Adherence to Oral Oncolytics

ASCO President Addresses Quality Care Through Collective Wisdom

Aggressive End-of-Life Care Continues to Be Offered to Younger Patients with Cancer

In the News, FDA Approvals

“Smart Bomb” First-in-Class Drug Rova-T Promising Novel Therapy for Small-Cell Lung Cancer

The Oncology Drug Pipeline Shows No Evidence of Slowing Down

NIH-Supported Research Outlines the Genetic Architecture of Type 2 Diabetes

CMS’s Andy Slavitt Considers Delaying MACRA Implementation

Improving Population Health by Working with Communities

David B. Nash, MD, MBA

Original Research

Impact of Pharmacist-Provided Medication Therapy Management on Healthcare Quality and Utilization in Recently Discharged Elderly Patients

Jordan D. Haag, PharmD, RPh, Amanda Z. Davis, PharmD, RPh, Robert W. Hoel, PharmD, RPh, Jeffrey J. Armon, PharmD, RPh, Laura J. Odell, PharmD, RPh, Ross A. Dierkhising, MS, Paul Y. Takahashi, MD

Stakeholder Perspective

A Systematic Approach to Medication Therapy Management in Elderly Patients with Chronic Diseases Can Improve Outcomes

by James T. Kennedy, Jr, RPh, MBA

Page 109 of 244
Results 1081 - 1090 of 2438